> ## Content Index
> Fetch the complete content index at: https://www.bullished.co/llms.txt
> Use this file to discover other available public pages before exploring further.

# DaVita Lifts Floor Of 2026 Profit Outlook After A $62 Million China Impairment
- URL: https://www.bullished.co/davita-lifts-floor-of-2026-profit-outlook-after-a-62-million-china-impairment-4ee39c1d/
- Published: 2026-10-29T21:16:03.000Z
- Updated: 2026-10-29T21:16:03.000Z
- Description: Adjusted operating income was $561 million in the third quarter, while cash flow fell well below a year earlier.
- Author: Matteo Parrino
- Tags: Earnings, DVA, Industry: Healthcare

[DaVita](https://www.bullished.co/tag/dva/), the kidney-care company built around dialysis, raised the low end of its 2026 profit forecast on Thursday even as a [$62 million non-cash China impairment](https://www.sec.gov/Archives/edgar/data/0000927066/000092706626000132/dva93026ex991.htm?ref=bullished.co) cut third-quarter earnings to $3.40 a share, or $3.82 on an adjusted basis. Revenue was $3.578 billion.

## China charge cuts into the quarter

The impairment pulled operating income to $499 million, a 14.0% margin, from $579 million and 16.3% in the second quarter. Adjusted operating income, which excludes the charge, was $561 million. Adjusted earnings per share of [$3.82 compared with](https://seekingalpha.com/news/4660759-davita-non-gaap-eps-of-3%5F82-beats-by-0%5F25-revenue-of-3%5F57b-beats-by-50m?ref=bullished.co) $4.02 in the second quarter.

The company said the charge was offset by a $1 million tax benefit and a $34 million credit to noncontrolling interests, leaving a $27 million hit to net income attributable to DaVita.

International posted an operating loss of $16 million against a $25 million profit in the second quarter. Integrated kidney care income fell to $4 million from $40 million.

## Cash flow trails last year

Operating cash flow was [$519 million](https://seekingalpha.com/news/4660759-davita-non-gaap-eps-of-3%5F82-beats-by-0%5F25-revenue-of-3%5F57b-beats-by-50m?ref=bullished.co), up from $490 million in the second quarter but below $842 million a year earlier. Free cash flow was $276 million, against $256 million in the second quarter and $604 million a year earlier.

DaVita narrowed its 2026 outlook. Adjusted operating income is now forecast at $2,175 million to $2,250 million, from $2,150 million to $2,250 million. Adjusted earnings per share is guided to $14.30 to $15.20, from $14.10 to $15.20\. The free cash flow range stays at $1,000 million to $1,250 million.

## Buybacks, debt and patient growth

DaVita spent $863 million repurchasing 5,837 thousand shares over nine months, including $111 million in the third quarter at an average $186.21 a share. Since September 30 through October 27, it bought another 0.5 million shares for $87 million. Shareholders' equity remains in deficit.

Debt was $10,832 million, a leverage ratio of 3.38x against a 5.00x covenant maximum. Normalized non-acquired treatment growth was 0.4% from a year earlier.

The U.S. dialysis business, the company's largest, earned $544 million in the quarter. DaVita counted about 80,800 patients in risk-based integrated care arrangements at September 30, up from 64,900 at June 30, representing about $6.4 billion in annualized medical spend.

DaVita holds its earnings call at 5:00 p.m. Eastern on Thursday.

Learn

- [Item 2.02: results of operations →](https://www.bullished.co/learn/8-k-items-explained/#item-202-results-of-operations)  
From 8-K Items Explained: What Every Item Code From 1.01 To 9.01 Tells You, With Examples

### Sources

- [8-K Filing — DAVITA INC. (DVA)](https://www.sec.gov/Archives/edgar/data/0000927066/000092706626000132/dva-20261029.htm?ref=bullished.co) — SEC EDGAR
- [Exhibit dva93026ex991.htm — DAVITA INC. 8-K exhibit](https://www.sec.gov/Archives/edgar/data/0000927066/000092706626000132/dva93026ex991.htm?ref=bullished.co) — SEC EDGAR
- [DaVita Non-GAAP EPS of $3.82 beats by $0.25, revenue of $3.57B beats by $50M (DVA:NYSE) | Seeking Alpha](https://seekingalpha.com/news/4660759-davita-non-gaap-eps-of-3%5F82-beats-by-0%5F25-revenue-of-3%5F57b-beats-by-50m?ref=bullished.co) — seekingalpha.com

### More on DaVita

- [DaVita's China Unit Has Zero Valuation Cushion After A $62 Million Impairment](https://www.bullished.co/davitas-china-unit-has-zero-valuation-cushion-after-a-62-million-impairment-bf7a804f/)

[All DaVita (DVA) coverage →](https://www.bullished.co/tag/dva/)